Prehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and Surgery
Physiatry-Led Prehabilitation During Neoadjuvant Systemic Treatment Before Breast Cancer Surgery: A Pilot Feasibility Study
3 other identifiers
interventional
20
1 country
2
Brief Summary
This clinical trial evaluates whether a prehabilitation program is feasible for breast cancer patients receiving neoadjuvant systemic treatment before surgery. Many people with breast cancer have problems during and after treatment. These issues can make daily activities harder and make it harder for a person to enjoy daily life. Some people with breast cancer already have other health problems, like joint pain or nerve problems, which can make these symptoms worse. Research shows that being stronger and more active before and during treatment may help people do better during cancer care and recover more easily. However, many patients do not get this type of support early enough. Prehabilitation is a program that helps patients get ready for cancer treatment and surgery. It may include help with medical care, exercise, food and nutrition, and mental health. The goal is to help patients stay as strong and healthy as possible before surgery. Starting prehabilitation during neoadjuvant systemic treatment before surgery may help breast cancer patients feel better, stay stronger and recover more easily during treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2027
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 15, 2026
CompletedStudy Start
First participant enrolled
February 24, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2029
Study Completion
Last participant's last visit for all outcomes
July 24, 2029
September 15, 2026
September 1, 2026
2.4 years
August 18, 2026
September 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence (feasibility)
Feasibility of exercise will be determined by participant adherence to the prescribed exercise for the evaluable preoperative study period with goal of adherence of \> 70% for \> 70% of the preoperative time period. Adherence is defined as a ratio of completed versus planned exercise amount (90 minutes per week of moderate intensity aerobic exercise when on neoadjuvant systemic treatment (NST), 150 minutes per week when off NST, and 2 times per week resistance exercise), averaged between the types of exercise. Feasibility of nutrition and mind/spirit practice will also be determined based on participant adherence (\> 70% of enrolled patients during the preoperative time period).
Up to day 168
Secondary Outcomes (16)
Six minute walk test
At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])
Duke Activity Status Index
At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])
30-second sit to stand
At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])
Short physical performance battery
At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])
Patient Reported Outcomes Measurement Information System Cancer Function Brief 3-dimensional Profile
At baseline, day 42, day 84, day 126, at pre-operative visit, and post-operative visit (21-35 days after surgery [approximately day 168])
- +11 more secondary outcomes
Study Arms (1)
Supportive care (prehabilitation)
EXPERIMENTALSee Detailed Description.
Interventions
Participate in aerobic exercise
Ancillary studies
Attend physiatry consultation
Receive prehabilitation education
Ancillary studies
Receive psychospiritual care
Participate in resistance exercise
Receive tailored prescriptions and recommendations
Eligibility Criteria
You may qualify if:
- Documented informed consent of the participant and/or legally authorized representative
- Willingness to comply with a physiatry consultation, start a tailored training program, and follow-up assessments
- Age: \>= 18 years
- Able to read and write in English
- A diagnosis of breast cancer planned for curative intent neoadjuvant systemic treatment (NST) with a goal of breast cancer surgery
- Plan to start NST at City of Hope Orange County
- Willingness to complete the Healthcare Team Feedback Survey
- \> 18 years old
- Physicians, advanced practice providers, nurses, medical assistants, rehabilitation therapists, social workers, dietitians, mental health professionals, and other clinical staff who interact with study participants in the course of routine care
You may not qualify if:
- Current or planned cancer treatment for a second cancer not of breast origin
- Clinically significant uncontrolled illness limiting participation with the research intervention and assessments
- Cancer with distant metastases
- Other active malignancy
- Pregnant or breastfeeding
- Physician judgment (based on information gathered during consult visit) of medical instability including conditions such as unstable cardiopulmonary status, recent embolism (\< 4 weeks), suspected or known dissecting aneurysm, severe hypertension (resting blood pressure \> 180/110), chronic infectious disease, uncontrolled metabolic disease (e.g. diabetes with ketosis), active seizure, mental/physical impairments limiting safe exercise, or sepsis
- Meeting or exceeding exercise guidelines over the last one month, based on the responses from the Godin Leisure-Time Physical Activity and Exercise Intent Questionnaire
- Started second cycle before the physiatry consult
- Inability to independently follow instructions for study assessments for any reason such as mental incapacitation or significant emotional or psychological disorder that, in the opinion of the investigators, precludes study entry. (These patients may not be able to cooperate with the prehabilitation interventions or with the data collection process.)
- Unable to independently answer questionnaires in English or provide informed consent for any reason
- Healthcare workers who do not interact with study participants and therefore cannot provide relevant feedback
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
City of Hope Medical Center
Duarte, California, 91010, United States
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Cheng
City of Hope Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2026
First Posted
September 15, 2026
Study Start (Estimated)
February 24, 2027
Primary Completion (Estimated)
July 24, 2029
Study Completion (Estimated)
July 24, 2029
Last Updated
September 15, 2026
Record last verified: 2026-09